scholarly journals Magnetic resonance imaging of the gastrointestinal tract shows reduced small bowel motility and altered chyme in cystic fibrosis compared to controls

Author(s):  
Neele S Dellschaft ◽  
Christabella Ng ◽  
Caroline Hoad ◽  
Luca Marciani ◽  
Robin Spiller ◽  
...  

AbstractCystic fibrosis (CF) is a genetic disease affecting mucosal secretions. Most patients experience digestive symptoms, but the mechanisms are incompletely understood. Here we explore causes and consequences of slower gastrointestinal transit using magnetic resonance imaging (MRI).Twelve people with CF and 12 healthy controls, matched for age and gender, underwent MRI scans both fasted and after standardised meals over a period of 6.5 hours. Images were assessed for small bowel motility, longitudinal relaxation time (T1) of ascending colon chyme, chyme texture and appearance of the colon wall.Small bowel motility scores were significantly lower in CF than in healthy controls in the fasting state (CF median 40 arbitrary units IQR [31, 46] vs Control 86 a.u. [52, 106], P=0.034). This difference was less pronounced postprandially. Furthermore, ascending colon chyme T1 was lower in CF than in controls (CF 0.59 s [0.38, 0.77] vs Control 0.79 s [0.55, 1.31], P=0.010). The difference in texture between small bowel and colon chyme, seen in health, was diminished in CF (difference in Haralick contrast 0.90 a.u. [0.38, 1.67] vs Control 2.11 a.u. [0.71, 3.30], P=0.010). Ascending colon mucosa in CF participants had an abnormal appearance compared to controls (Score 1-3, CF 2 [1, 3] vs Controls 1 [1, 1], P=0.019).Reduced small bowel motility and water content of ascending colon chyme are consistent with slower transit and constipation. MRI provides unique insights into chyme texture in the small bowel (suggesting bacterial overgrowth) and the appearance of the colon mucosa (suggesting altered mucus) in CF.Key point summary-People with cystic fibrosis (CF) have intrusive digestive symptoms and severe gut complications, but mechanisms are incompletely understood.-In this study, 12 people with CF were compared to healthy controls, undergoing repeated MRI scans before and after standardised meals.-Fasted small bowel motility is reduced in people with CF, consistent with slower transit. In addition, a reduced colonic chyme water content and abnormal appearance of small bowel and colonic chyme as well as colonic mucosa suggest small bowel bacterial overgrowth, fat malabsorption and abnormal mucus production-These MRI outcomes hold promise in the assessment of therapeutic interventions.

2016 ◽  
Vol 150 (4) ◽  
pp. S97 ◽  
Author(s):  
Jigar Bhagatwala ◽  
Siegfried W. Yu ◽  
Askin Erdogan ◽  
Pornchai Leelasinjaroen ◽  
Amol Sharma ◽  
...  

PLoS ONE ◽  
2018 ◽  
Vol 13 (1) ◽  
pp. e0191044 ◽  
Author(s):  
Akitoshi Inoue ◽  
Akira Furukawa ◽  
Hiroshi Yamamoto ◽  
Shinichi Ohta ◽  
Nguyen Dai Hung Linh ◽  
...  

2003 ◽  
Vol 15 (3) ◽  
pp. 267-276 ◽  
Author(s):  
I. D. Van felius ◽  
L. M. A. akkermans ◽  
K. bosscha ◽  
A. Verheem ◽  
W. Harmsen ◽  
...  

1998 ◽  
Vol 10 (12) ◽  
pp. A40
Author(s):  
V. B. Nieuwenhuijs ◽  
H. van Duijvenbode-Beumer ◽  
A. Verheem ◽  
M. R. Visser ◽  
J. Verhoef ◽  
...  

2019 ◽  
Vol 111 (1) ◽  
pp. 131-140
Author(s):  
Asseel Khalaf ◽  
Caroline L Hoad ◽  
Alex Menys ◽  
Adam Nowak ◽  
Shellie Radford ◽  
...  

ABSTRACT Background Crohn's disease (CD) patients suffer postprandial aversive symptoms, which can lead to anorexia and malnutrition. Changes in the regulation of gut hormones and gut dysmotility are believed to play a role. Objectives This study aimed to investigate small-bowel motility and gut peptide responses to a standard test meal in CD by using MRI. Methods We studied 15 CD patients with active disease (age 36 ± 3 y; BMI 26 ± 1 kg/m 2) and 20 healthy volunteers (HVs; age 31 ± 3 years; BMI 24 ± 1 kg/m 2). They underwent baseline and postprandial MRI scans, symptom questionnaires, and blood sampling following a 400-g soup meal (204 kcal). Small-bowel motility, other MRI parameters, and glucagon-like peptide-1 (GLP-1), polypeptide YY (PYY), and cholecystokinin peptides were measured. Data are presented as means ± SEMs. Results HVs had significantly higher fasting motility indexes [106 ± 13 arbitrary units (a.u.)], compared with CD participants (70 ± 8 a.u.; P ≤ 0.05). Postprandial small-bowel water content showed a significant time by group interaction (P < 0.05), with CD participants showing higher levels from 210 min postprandially. Fasting concentrations of GLP-1 and PYY were significantly greater in CD participants, compared with HVs [GLP-1, CD 50 ± 8 µg/mL versus HV 13 ± 3 µg/mL (P ≤ 0.0001); PYY, CD 236 ± 16 pg/mL versus HV 118 ± 12 pg/mL (P ≤ 0.0001)]. The meal challenge induced a significant postprandial increase in aversive symptom scores (fullness, distention, bloating, abdominal pain, and sickness) in CD participants compared with HVs (P ≤ 0.05). Conclusions The decrease in fasting small-bowel motility noted in CD participants can be ascribed to the increased fasting gut peptides. A better understanding of the etiology of aversive symptoms in CD will facilitate identification of better therapeutic targets to improve nutritional status. This trial was registered at clinicaltrials.gov as NCT03052465.


2005 ◽  
Vol 21 (4) ◽  
pp. 370-375 ◽  
Author(s):  
Johannes M. Froehlich ◽  
Michael A. Patak ◽  
Constantin von Weymarn ◽  
Christoph F. Juli ◽  
Christoph L. Zollikofer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document